Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria

10 Feb 2016

Abstract excerpt

High Resolution Image Download MS PowerPoint Slide In order to identify the most attractive starting points for drugs that can be used to prevent malaria, a diverse chemical space comprising tens of thousands to millions of small molecules may need to be examined. Achieving this throughput necessitates the development of efficient ultra-high-throughput screening methods. Here, we report the development and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Malaria Research and Control
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27275010
DOI: 10.1021/acsinfecdis.5b00143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaPMID 27275010Read ↗

Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicitySemantic proximity Read ↗

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.Semantic proximity Read ↗

Phenotypic Screens in Antimalarial Drug Discovery.Semantic proximity Read ↗

Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-outSemantic proximity Read ↗

Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of actionSemantic proximity Read ↗

Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum GametocytesSemantic proximity Read ↗

Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of <i>Plasmodium falciparum</i> reveals several inhibitory compoundsSemantic proximity Read ↗

Pyrimidine Azepine Targets the Plasmodium bc 1 Complex and Displays Multistage Antimalarial ActivitySemantic proximity Read ↗

Identification of MMV Malaria Box Inhibitors of Plasmodium falciparum Early-Stage Gametocytes Using a Luciferase-Based High-Throughput AssaySemantic proximity Read ↗

Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box MoleculesSemantic proximity Read ↗

Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage <i>Plasmodium falciparum</i> , using a nano luciferase reporter read-outSemantic proximity Read ↗

Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profilesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.